Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,567

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

for

Endometrial Cancer, Cervical Cancer

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT06925724

Phase2, Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for

Metastatic Colorectal Carcinoma,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase3, Recruiting

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

for

Myelofibrosis

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06773195

Phase1, Phase2, Recruiting

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

for

Urothelial Carcinoma

Location: New York NY, Montvale NJ, Rockville Centre NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05239624

Phase2, Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

for

Mesothelin Positive, Mesothelin-Expressing Tumors,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06623396

Phase1, Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

for

B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable,

Location: New York NY, Montvale NJ, Rockville Centre NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04512716

Early_phase1, Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

for

Metastatic Non-small Cell Lung Cancer

Location: New York NY, Hackensack NJ, Montvale NJ, Uniondale NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04410796

Phase2, Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

for

Refractory Acute Myeloid Leukemia,

Location: New York NY, Montvale NJ, Rockville Centre NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT06017258

Phase1, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for

Mantle Cell Lymphoma, B Cell Lymphoma

Location: New York NY, Paramus NJ, New Haven CT, West Reading PA,

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

for

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06057935

Phase2, Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

for

Multiple Myeloma

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05623020

Phase3, Recruiting

A Study of CRD3874-SI in People With Solid Tumors

for

Sarcoma, Merkel Cell Carcinoma

Location: New York NY, Montvale NJ, Rockville Centre NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06021626

Phase1, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,

Location: New York NY, Hackensack NJ, The Bronx NY, Morristown NJ,

Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

for

Monoclonal Gammopathy of Undetermined Significance,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05640843

Recruiting

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

for

Metastatic Renal Cell Carcinoma,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06835972

Phase1, Phase2, Recruiting

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

for

Myelofibrosis Due to and Following Polycythemia Vera

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05714072

Phase1, Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

for

Non-muscle Invasive Bladder Cancer

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05126472

Phase1, Phase2, Recruiting

A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

for

Multiple Myeloma

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06066346

Phase2, Recruiting

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for

Multiple Myeloma

Location: New York NY, Hackensack NJ, The Bronx NY,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05201781

Recruiting

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

for

Endometrial Cancer, Stage III Endometrial Cancer,

Location: New York NY, Montvale NJ, Uniondale NY, Middletown NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT05691010

Early_phase1, Recruiting

Paid Clinical Trials Jersey City

Filter results

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Interested in new trials?

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

A Study of CRD3874-SI in People With Solid Tumors

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer